Imaging Endpoints
Oncology imaging CRO that designs, reads and analyses imaging endpoints for pharma sponsors' clinical trials
Highlights
- New on EvolcAdded 2026-11-01
About Imaging Endpoints
Imaging Endpoints is an oncology-focused imaging contract research organisation (iCRO) and core laboratory. It designs and deploys imaging for early-stage trials, carries imaging analysis into late-stage trials and supports regulatory submissions. Services include customised imaging criteria, advanced acquisition and post-processing such as radiomics with AI, and real-time image receipt, query management and reads.
Its customers are pharmaceutical and biotechnology sponsors running oncology clinical trials. Work is delivered by physician readers, imaging scientists, and regulatory and operations specialists.
Founded in 2021 and headquartered in Harrow, United Kingdom. The company also has offices in Scottsdale, Arizona; Cambridge, Massachusetts; Hyderabad; Shanghai; Basel; Leiden; and London. It is affiliated with HonorHealth and Southwest Medical Imaging (SMIL / RadPartners).
Product: Oncology clinical trial imaging services: trial imaging design, central imaging reads, advanced imaging analysis and regulatory submission support.
Jobs at Imaging Endpoints
Leadership
- Ron Korn · Founder and Chief Medical OfficerSource: company website
- Doug Dean Burkett · Chief Executive Officer and PresidentSource: company website
- Jatinder Kaur · Chief Operating OfficerSource: company website
- Madhavi Darbha · Chief Financial and People Operations OfficerSource: company website
More biotech & pharma companies
immunesystems.co.uk
UK supplier of antibodies, ELISA kits, labeling kits and lab reagents for life sciences researchers and producersNew on EvolcImmunocore
Biotech developing ImmTAX-based T cell receptor therapies for cancer, infectious and autoimmune diseasesNew on EvolcImmunokey
Develops CAR T-cell therapies for solid cancers, starting with ovarian cancerYoung companyNew on Evolcimmunologicaltoolbox.co.uk
Online antibody repository for veterinary immunology researchers, with community ratings and reagent requestsNew on EvolcImmutrin
Develops antibody therapies to remove amyloid deposits for people with amyloidosis, including ATTR cardiomyopathyNew on EvolcIMU Biosciences
Immune profiling and precision-medicine tools for clinical research, pharmaceutical, biotech and diagnostics organizationsRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
CRM & customer data
- HubSpotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.